Jan K Buitelaar Selected Research

Methylphenidate (Ritalin)

1/2022	Dorsal-to-ventral imbalance in the superior longitudinal fasciculus mediates methylphenidate's effect on beta oscillations in ADHD.
1/2022	Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis.
1/2022	Withdrawing methylphenidate in relation to serum levels of ferritin and zinc in children and adolescents with attention-deficit/hyperactivity disorder.
12/2021	Effects of methylphenidate on executive functioning in children and adolescents with ADHD after long-term use: a randomized, placebo-controlled discontinuation study.
1/2021	Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis.
9/2020	Annual variation in attentional response after methylphenidate treatment.
12/2019	Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence.
1/2019	Methylphenidate Dose-Dependently Affects Aggression and Improves Fear Extinction and Anxiety in BALB/cJ Mice.
1/2019	Continued Benefits of Methylphenidate in ADHD After 2 Years in Clinical Practice: A Randomized Placebo-Controlled Discontinuation Study.
1/2018	Electroencephalographic biomarkers as predictors of methylphenidate response in attention-deficit/hyperactivity disorder.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jan K Buitelaar Research Topics

Disease

96	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 01/2004
32	Autism Spectrum Disorder 01/2021 - 12/2002
12	Autistic Disorder (Autism) 01/2021 - 12/2002
6	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2021 - 03/2016
5	Mental Disorders (Mental Disorder) 12/2020 - 11/2009
5	Hyperprolactinemia 09/2013 - 08/2009
4	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 02/2009
4	Conduct Disorder (Conduct Disorders) 01/2020 - 01/2012
3	Schizophrenia (Dementia Praecox) 01/2022 - 11/2018
3	Weight Gain 01/2022 - 11/2005
3	Substance-Related Disorders (Drug Abuse) 04/2017 - 11/2009
3	Motor Skills Disorders (Motor Skills Disorder) 10/2013 - 01/2011
2	Headache (Headaches) 01/2022 - 05/2008
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 11/2018
2	Psychotic Disorders (Schizoaffective Disorder) 01/2019 - 01/2016
2	Neurodevelopmental Disorders 01/2017 - 12/2013
2	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 09/2014 - 05/2010
2	Galactorrhea 09/2013 - 08/2009
2	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 12/2012 - 12/2012
2	Fatigue 07/2012 - 05/2010
2	Alcoholism (Alcohol Abuse) 04/2012 - 04/2011
1	Oppositional Defiant Disorder 01/2022
1	Anorexia Nervosa 01/2022
1	COVID-19 01/2021
1	Antisocial Personality Disorder (Antisocial Personality) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 12/2019
1	Brain Diseases (Brain Disorder) 11/2018
1	Obesity 02/2018
1	Intellectual Disability (Idiocy) 04/2017
1	Tics (Tic) 01/2017
1	Tourette Syndrome (Tourette's Syndrome) 01/2017
1	Dementia (Dementias) 03/2016
1	Tobacco Use Disorder (Nicotine Dependence) 01/2016
1	Hepatitis 01/2016

Drug/Important Bio-Agent (IBA)

29	Methylphenidate (Ritalin)FDA LinkGeneric 01/2022 - 01/2004
15	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2022 - 07/2004
15	Biological ProductsIBA 01/2021 - 12/2002
14	Biomarkers (Surrogate Marker)IBA 10/2021 - 12/2002
9	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2003
9	Dopamine (Intropin)FDA LinkGeneric 01/2019 - 01/2003
8	Glutamic Acid (Glutamate)FDA Link 01/2021 - 05/2015
7	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021 - 02/2009
7	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017 - 01/2005
6	Dopamine Receptors (Dopamine Receptor)IBA 01/2017 - 01/2005
5	Antipsychotic Agents (Antipsychotics)IBA 12/2020 - 08/2009
4	Risperidone (Risperdal Consta)FDA LinkGeneric 09/2013 - 11/2005
4	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2007 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 12/2019 - 04/2011
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2019 - 10/2008
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019 - 01/2003
3	Protons (Proton)IBA 01/2018 - 05/2015
3	Pharmaceutical PreparationsIBA 03/2014 - 06/2004
3	ProlactinIBA 09/2013 - 08/2009
2	Insulin (Novolin)FDA Link 01/2022 - 12/2019
2	AmphetaminesIBA 01/2022 - 03/2017
2	ORALIT (ORS)IBA 01/2022 - 01/2013
2	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022 - 03/2014
2	Nicotine FDA Link 10/2017 - 01/2016
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2013 - 02/2008
2	dicarboxydine (DCD)IBA 03/2012 - 01/2011
2	3' Untranslated Regions (3' UTR)IBA 07/2011 - 08/2009
1	Ferritins (Ferritin)IBA 01/2022
1	agomelatine (S20098)IBA 01/2022
1	Modafinil (Provigil)FDA Link 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	Clonidine (ST 155)FDA LinkGeneric 01/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	IronIBA 01/2022
1	Insulin ReceptorIBA 01/2022
1	ZincIBA 01/2022
1	Guanfacine (Tenex)FDA LinkGeneric 01/2022
1	Bupropion (Wellbutrin)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	4-aminospiroperidolIBA 01/2020
1	Inosine Monophosphate (IMP)IBA 09/2019
1	Biological FactorsIBA 10/2018
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2018
1	CreatineIBA 01/2018
1	Caseins (Casein)FDA Link 09/2017
1	Food Additives (Food Additive)IBA 09/2017
1	Nitric Oxide Synthase (NO Synthase)IBA 08/2017
1	Glucose (Dextrose)FDA LinkGeneric 07/2017
1	Messenger RNA (mRNA)IBA 07/2017
1	Adenosine Monophosphate (AMP)IBA 03/2017
1	16S Ribosomal RNAIBA 01/2017
1	Memantine (Namenda)FDA Link 03/2016
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2016
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2016

Therapy/Procedure

4	Neurofeedback 01/2017 - 08/2013
2	Drug Therapy (Chemotherapy) 10/2015 - 12/2014
2	Psychology Biofeedback (Biofeedback) 03/2015 - 03/2013
2	Secondary Prevention 08/2004 - 07/2004
1	Continuity of Patient Care 01/2022
1	Critical Care (Surgical Intensive Care) 01/2021
1	Treatment Delay 01/2021
1	Therapeutics 01/2020
1	Precision Medicine 10/2019
1	Phototherapy (Light Therapy) 02/2018
1	Gluten-Free Diet 09/2017